This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through November 3, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Microcap Article: Archive
ImmuCell Q3 Earnings Decline Y/Y, Sales Grow Amid Margin Challenges
by Zacks Equity Research
ICCC sees strong Q3 sales growth but faces challenges with margins. It awaits FDA approval for its groundbreaking Re-Tain product.
ICCCPositive Net Change
earnings medical
Smith-Midland Q3 Earnings Skyrocket 146% Y/Y, Revenues Soar 51%
by Zacks Equity Research
Smith-Midland posts Q3 revenues of $23.6 million, driven by service growth and higher margins, boosting earnings per share to 59 cents.
SMIDNegative Net Change
construction earnings
Nova LifeStyle Stock Falls Despite Q3 Earnings Uptick Y/Y, Revenues Up
by Zacks Equity Research
NVFY reports third-quarter losses as operational costs rise. Sales growth in North America offers a glimmer of hope.
consumer-discretionary earnings
MiT's Earnings Break Even in Q1 Amid Revenue and Demand Struggles
by Zacks Equity Research
MITQ posts Q1 breakeven earnings with a 20.8% revenue decline, impacted by post-COVID recovery challenges and softer demand, while maintaining R&D investments to drive future growth.
MITQNegative Net Change
business-services earnings
Jones Soda Reports Wider Y/Y Q3 Loss Amid Revenue Drop & Rising Costs
by Zacks Equity Research
JSDA faces a wider y/y Q3 loss as revenues dip 6.4% and costs rise, led by product investments, legal expenses and distribution challenges.
JSDAPositive Net Change
consumer-staples earnings
VASO Stock Up Despite Q3 Earnings Decline and Rising Costs
by Zacks Equity Research
Vaso posts third-quarter 2024 revenue growth, but higher costs and a net loss affect profitability.
VASOPositive Net Change
earnings medical medical-devices
Elite Pharmaceuticals' Stock Up Despite Q2 Earnings Decline
by Zacks Equity Research
ELTP sees strong revenue growth despite a net loss, driven by new product launches and strategic acquisitions.
ELTPNegative Net Change
earnings medical
Mega Matrix Reports Wider Y/Y Q3 Loss but Outpaces Market Trends
by Zacks Equity Research
MPU posts third-quarter revenues of $10.3 million, led by FlexTV growth. The company's stock has gained 16.6% in a month as it expands globally with no debt and a strong cash flow.
MPUNo Net Change
consumer-discretionary earnings
NetSol Reports Y/Y Revenue Growth in Q1 but Faces Earnings Challenges
by Zacks Equity Research
NTWK posts 3% revenue growth in first-quarter fiscal 2025, driven by a 26% rise in recurring revenues. Operating losses widen as expenses climb.
NTWKPositive Net Change
earnings tech-stocks
Espey Shares Down Despite Solid Y/Y Q1 Earnings Growth
by Zacks Equity Research
ESP posts strong EPS growth, along with a 21.9% revenue increase in fiscal first-quarter 2025, driven by a strong backlog. New orders dip, but management anticipates recovery.
ESPNegative Net Change
aerospace earnings
BKTI Stock Rises After Q3 Earnings Boost Margins and Profitability
by Zacks Equity Research
BK Technologies reports strong third-quarter 2024 results with improved margins, higher net income and raised EPS guidance, driving stock gains.
BKTINegative Net Change
communications earnings tech-stocks
NeurAxis Stock Surges After Strong Q3 Earnings and Expanded Coverage
by Zacks Equity Research
NRXS reports strong third-quarter results with rising revenues, reduced losses and expanded insurance coverage, driving its stock to outperform the market.
NRXSPositive Net Change
earnings medical medical-devices
Where Food Comes From Stock Declines Since Reporting Mixed Q3 Results
by Zacks Equity Research
WFCF sees marginal y/y revenue growth in Q3, but earnings dip 30.8%. Stock declines amid beef market challenges and increased operating costs.
WFCFNo Net Change
consumer-discretionary earnings
CVD Equipment Stock Up Post Q3 Earnings on Revenue and Profit Growth
by Zacks Equity Research
CVV posts strong third-quarter results with revenue growth and backlog gains, driven by aerospace demand and strategic initiatives.
CVVPositive Net Change
earnings industrial-products
Sypris Q3 Earnings Rise Y/Y on Defense Demand, 2024 View Updated
by Zacks Equity Research
SYPR reports Q3 earnings growth on a year-over-year basis, driven by defense demand and a strong backlog. It is updating its 2024 revenue outlook amid steady demand across sectors.
SYPRNegative Net Change
computers earnings tech-stocks
DallasNews Incurs Q3 Loss, Widens Y/Y, Shares Up 5%
by Zacks Equity Research
DALN reports a wider Q3 loss, along with advertising revenue challenges, offset by digital growth focus and cost-cutting efforts to achieve sustainable profitability.
consumer-staples earnings
EVI Industries' Q1 Earnings Up Y/Y on Tech Upgrades, Shares Down 10%
by Zacks Equity Research
EVI reports strong Q1 earnings growth, driven by strategic acquisitions and tech upgrades, but shares dip 9.9% as the broader market outperforms.
EVIPositive Net Change
earnings industrial-products
Better Choice Shares Down Despite Posting Strong Q3 Earnings
by Zacks Equity Research
BTTR reports strong third-quarter 2024 results, with 194% year-over-year net income rise, marking its first profitable quarter over four years.
earnings retail
Air T Stock Rises Post Q2 Earnings on Higher Revenue, Operating Income
by Zacks Equity Research
AIRT reports revenue growth and higher operating income in the second quarter of fiscal 2025, driving stock gains. Strong segments include overnight air cargo and jet engines and parts.
AIRTPositive Net Change
earnings transportation
Mobile Infrastructure Stock Down Post Q3 Earnings Despite Revenue Gain
by Zacks Equity Research
BEEP reports third-quarter revenue growth, with gains in managed property revenue and reaffirmed guidance for 2024.
BEEPPositive Net Change
earnings finance real-estate
Friedman Stock Declines Post Q2 Earnings on Lower Sales, Demand
by Zacks Equity Research
FRD faces declining sales and demand in second-quarter fiscal 2025, impacting its stock price.
FRDPositive Net Change
earnings industrial-products
FONR Stock Gains Despite Q1 Earnings Dip and Rising Expenses
by Zacks Equity Research
FONAR's fiscal first-quarter earnings reveals a decline in revenues and income, driven by decreased patient fees and rising costs, while MRI scan volume sees modest growth.
FONRNegative Net Change
earnings medical medical-devices
CRWS Stock Down Following Q2 Earnings Decline Y/Y, Revenue Up
by Zacks Equity Research
Crown Crafts sees fiscal second-quarter revenue boost from Baby Boom acquisition, but legacy sales drop amid economic challenges. Higher costs affect net income and profits.
CRWSNegative Net Change
consumer-discretionary earnings
United-Guardian Reports Y/Y Rise in Q3 Earnings, Flat Revenues
by Zacks Equity Research
UG's Q3 earnings gain from effective cost management and increased demand for its cosmetic ingredients segment.
UGPositive Net Change
earnings medical
Team Reports Year-Over-Year Growth in Q3 Earnings and Revenues
by Zacks Equity Research
Growth in the U.S. operations and cost efficiencies aid TISI's earnings in Q3.
TISINegative Net Change
construction earnings